Table of Contents Author Guidelines Submit a Manuscript
Bioinorganic Chemistry and Applications
Volume 2013, Article ID 198545, 11 pages
http://dx.doi.org/10.1155/2013/198545
Research Article

Characterization of Tibetan Medicine Zuota by Multiple Techniques

Institute of Ethnic Medicine, Southwest University for Nationalities, Chengdu 610041, China

Received 21 April 2013; Accepted 5 August 2013

Academic Editor: Claudio Pettinari

Copyright © 2013 Xiao-Yan Zhao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Žuškin, J. Lipozenčić, J. Pucarin-Cvetković et al., “Ancient medicine A,” Acta Dermatovenerologica Croatica, vol. 16, no. 3, pp. 149–157, 2008. View at Google Scholar · View at Scopus
  2. Y. Yutuo, Medical Canon in Four Sections (Si Bu Yi Dian, Chinese Version), translated by Y. Li, People’s Publishing House, Beijing, China, 1983.
  3. D. Luo, New Repair Jingzhu Materia Medica (Jing Zhu Ben Cao, Chinese Version), translated by J. Mao D. Luo, Z. Wang, and S. Ma, Shanghai Science and Technology Press, Shanghai, China, 1986.
  4. S. Wang, “Clinical observation of Tibetan drug with Songshi-25 pill for chronic hepatitis B,” China Journal of Chinese Materia Medica, vol. 5, no. 4, p. 10, 1999. View at Google Scholar
  5. B. Yang, Y. Zhang, T. Huang et al., “Clinical observation of chronic superficial gastritis (Syndrome differentiation of TCM Being hepatic Qi attacking stomach) Tibetan drug Zuo-ta-de-zi-ma, attaching with clinical report of 149 cases,” Journal of Chengdu University of Traditional Chinese Medicine, vol. 24, no. 1, pp. 14–16, 2001. View at Google Scholar
  6. M.-C. Wan, J.-S. Lou, and Y.-W. Qin, “Application of Rannasangpei in the treatment of cardiovascular and cerebrovascular diseases,” Pharmaceutical Care and Research, vol. 9, no. 4, pp. 283–285, 2009. View at Google Scholar · View at Scopus
  7. C. Zhang, X. Pan, W. Qiu, B. Shi, J. Chang, and Y. Ni, “59 clinical reports of Tibetan drug with Songshi-25 pill for chronic hepatitis B,” Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases, vol. 9, no. 3, pp. 28–29, 1999. View at Google Scholar
  8. C. Limao and J. Qie, “62 clinical reports of dispersing stagnated liver qi for regulating stomach and detoxification for chronic gastritis treatment,” Chinese Medicine Modern Distance Education of China, vol. 7, no. 11, pp. 88–89, 2009. View at Google Scholar
  9. J. Yang, J. Deng, D. Li, and J. Li, “Jintang village investigation: one consideration about the cause of Pa-disease,” Chinese Journal of Endemiology, vol. 19, no. 1, pp. 36–40, 2000. View at Google Scholar
  10. Y. Zhang and Y. Xiang, “To analyze the usage of toxicant in traditional Tibetan medicine based on 64 dermatological formulas by oral administration,” World Science and Technology/Modernization of Traditional Chinese Medicine and Materia Medica, vol. 7, pp. 64–66, 2005. View at Google Scholar
  11. B. Yang, “The pharmacology and safety of mercury in Tibetan medicine Zuota,” Tibet Research, no. 1, pp. 74–80, 2004. View at Google Scholar
  12. Z. Chen, X. Pu, W. Li, K. Wu, G. Lan, and J. Cui, “Influence of Tibetan medicine Zuota on the life of fruit fly,” Lishizhen Medicine and Materia Medica Research, vol. 22, no. 2, pp. 422–423, 2011. View at Google Scholar
  13. http://www.ihchina.cn/inc/guojiaminglunry.jsp?gjml_id=448.
  14. L. Suo, “Processing of Zuota,” Journal of Medicine & Pharmacy of Chinese Minorities, no. 5, p. 40, 2007. View at Google Scholar
  15. B. A. Bowman and R. M. Russell, Present Knowledge in Nutrition, The International Life Sciences Institute, Washington, DC, USA, 9th edition, 2006.
  16. J. M. Llobet, G. Falcó, C. Casas, A. Teixidó, and J. L. Domingo, “Concentrations of arsenic, cadmium, mercury, and lead in common foods and estimated daily intake by children, adolescents, adults, and seniors of Catalonia, Spain,” Journal of Agricultural and Food Chemistry, vol. 51, no. 3, pp. 838–842, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Dou, “Analysing the toxicity of Tibetan pharmacist-prepared medicine in “Zuo Tai” as well as its compatibility,” Journal of Qinghai Junior Teachers’ College, no. 4, pp. 72–75, 2005. View at Google Scholar
  18. X. Li, W. Feng, Q. Ma, J. Zhu, C. Nima, and R. Ge, “Preliminary study on the absorption and excretion of mercury in Tibetan medicine Zuotai in rats,” Lishizhen Medicine and Materia Medica Research, vol. 21, no. 2, pp. 290–292, 2010. View at Google Scholar
  19. A. Jiang, C. Zhang, J. Wang et al., “Pharmacodynamics research of Tibetan medicine Zuotai,” Lishizhen Medicine and Materia Medica Research, vol. 20, no. 8, pp. F3–F4, 2009. View at Google Scholar
  20. X.-Y. Li, W.-L. Feng, J.-B. Zhu, C.-R. Nima, and R.-L. Ge, “Effect of Tibetan medicine Zuotai on in vivo pharmacokinetics of crocin-1 in rats,” Chinese Traditional and Herbal Drugs, vol. 40, no. 9, pp. 1425–1428, 2009. View at Google Scholar · View at Scopus
  21. Y. Zeng, Y. He, Y. Liu, Z. Wang, and Y. Zhang, “Pharmacological effect of Tibetan medicine Zuota to central nervous system,” Journal of Sichuan of Traditional Chinese Medicine, no. 11, pp. 36–37, 2005. View at Google Scholar
  22. Y. Zeng, P. Wang, Y. He, and Y. Zhang, “Determination of Hg in Zuota (a Tibetan medicine) by HPLC,” Central South Pharmacy, vol. 6, no. 1, pp. 60–63, 2008. View at Google Scholar
  23. G. Lan, Z. Chen, W. Li, K. Wu, J. Cui, and L. Piao, “Analysis on chemical constituents of Tibetan medcine Zogta,” Lishizhen Medicine and Mataeria Medica Research, vol. 21, no. 12, pp. 3209–3211, 2010. View at Google Scholar
  24. L. Yan, “Microstructure and component of Tibetan medicine Zuotai,” China Tibetology, no. 3, pp. 150–152, 2007. View at Google Scholar
  25. L. Yan, X. Ma, and Q. Zhu, “Inorganic components analysis of Tibetan medicine Zuotai,” China Journal of Chinese Materia Medica, vol. 32, no. 2, pp. 159–160, 2007. View at Google Scholar
  26. L. Yan and X. Ma, “The chemical and structural analysis of carbon in Ttibetan medicine Zuotai,” Chinese Journal of Ethnomedicine and Ethnopharmacy, vol. 19, no. 5, pp. 1–2, 2010. View at Google Scholar
  27. T. L. Doane and C. Burda, “The unique role of nanoparticles in nanomedicine: Imaging, drug delivery and therapy,” Chemical Society Reviews, vol. 41, no. 7, pp. 2885–2911, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. M. E. Lobatto, V. Fuster, Z. A. Fayad, and W. J. M. Mulder, “Perspectives and opportunities for nanomedicine in the management of atherosclerosis,” Nature Reviews Drug Discovery, vol. 10, no. 11, pp. 835–852, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Mout, D. F. Moyano, S. Rana, and V. M. Rotello, “Surface functionalization of nanoparticles for nanomedicine,” Chemical Society Reviews, vol. 41, no. 7, pp. 2539–2544, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Sasmaz, Fundamental understanding of mercury removal from coal combustion [Ph.D. dissertation], Stanford University, 2011.
  31. G. Hota, S. B. Idage, and K. C. Khilar, “Characterization of nano-sized CdS-Ag2S core-shell nanoparticles using XPS technique,” Colloids and Surfaces A, vol. 293, no. 1-3, pp. 5–12, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. S.-T. Yang, S. Chen, Y. Chang, A. Cao, Y. Liu, and H. Wang, “Removal of methylene blue from aqueous solution by graphene oxide,” Journal of Colloid and Interface Science, vol. 359, no. 1, pp. 24–29, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Yang, J. Luo, J. Liu et al., “Carbon nanoparticles for cationic dye (methylene blue) removal from aqueous solution,” Nanoscience and Nanotechnology Letters, vol. 4, no. 8, pp. 839–842, 2012. View at Google Scholar